ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction]

Cheng J, Wang R, Zhong G, et al. Onco Targets Ther. 2020;13:903–914.

At the author’s request, we, the Editors and Publisher of OncoTargets and Therapy have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figure 4 with images from other unrelated articles. Specifically,

• Images for Figure 4B have been duplicated with images for Figure 4a from Luo N, Guo J, Chen L, et al. ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells. Cell Death Dis. 2016;7:e2157. https://doi.org/10.1038/cddis.2015.401; Figure 6A from Tantai J, Zhang Y, Zhao H. Heterophyllin B inhibits the adhesion and invasion of ECA‑109 human esophageal carcinoma cells by targeting PI3K/AKT/β‑catenin signaling. Molecular Medicine Reports. 2016;13:1097-1104. https://doi.org/10.3892/mmr.2015.4659 and Figure 8A from Zhang W, Liang Z, Li J. Inhibition of rhotekin exhibits antitumor effects in lung cancer cells. Oncology Reports. 2016;35:2529-2534. https://doi.org/10.3892/or.2016.4634.
• The image for Figure 4C, MCF-7, Control, have been duplicated with the image for Figure 4C, HO-8910, WT, from Cheng Z, Guo J, Chen L, et al. Overexpression of TMEM158 contributes to ovarian carcinogenesis. J Exp Clin Cancer Res. 2015;34:75. https://doi.org/10.1186/s13046-015-0193-y.

The authors were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the authors requested to retract the article and the Editor and Publisher agreed with this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.